Athersys Inc. (Nasdaq: ATHX) partnered with Healios to develop and commercialize cell therapy treatment MultiStem to treat ischemic stroke in Japan. Shares of the biotechnology company gained 22 cents to $1.25.
Athersys partners with Healios
January 08, 2016 at 12:15 PM EST
